Live Breaking News & Updates on தாமதமாக கிங் ராமா|Page 1

Stay updated with breaking news from தாமதமாக கிங் ராமா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Thailand: Covid-19 and the Vaccine

Article by Anthony Margetts CEng MIChemE
How the Covid-19 vaccine development is progressing in Thailand
THAILAND is a developing country in the Asean Region of SE Asia with a population of 66m and also several million migrant workers from Myanmar and Cambodia who work in the food production and construction industries. In 2019 Thailand received 35m visitors from many parts of the world to visit the spectacular beaches, mountains and temples. A dramatic consequence of the Covid-19 pandemic is that there are now no visitors, and the tourist areas are very quiet.
Thailand is also a globally-renowned wellness hub and has attracted millions of foreign patients in previous years. Its public healthcare is highly rated, and was ranked the sixth-best healthcare provider in 2019, according to analysis conducted by magazine ....

Krung Thep Mahanakhon , Bang Khae , New South Wales , United States , South Korea , Sara Buri , Pathum Thani , Boonrak Thawornrungroaj , Nick White , King Monkut , Baiya Phytopharm , Nakorn Premsri , Queen Savang Vadhana , Human Research Ethics Committee , National Health Security Office , Faculty Of Tropical Medicine At Mahidol University , Merieux Biological Products Co , Government Pharmaceutical Organization , University Of Sydney , Health Coverage , Oxford University , National Vaccine Committee , National Vaccine Institute , Chulalongkorn University Faculty Of Pharmaceutical Sciences , Texas University , Department Of Disease Control ,

Siam Bioscience strives to be the leading COVID-19 vaccine producer for Southeast Asia

published :
25 Jan 2021 at 16:15
8
Siam Bioscience Co., Ltd., the first and only biopharmaceuticals manufacturer in Thailand, was founded in 2009 to preserve and continue what His Majesty the Late King Rama IX started on behalf of the Thai people’s health and wellbeing.
The company’s main products are biopharmaceuticals. Its first product was erythropoietin (EPO) which is used to treat chronic renal failure patients who can no longer produce sufficient red blood cells, resulting in anaemia. Its second product was filgrastim (GCSF) for cancer patients receiving chemotherapy, who have high risk of infection due to low white blood cell counts. Manufactured using state-of-the-art biotechnology, both of these medicines are effective treatments with low side effects. ....

Nualphan Lamsam , Corporate Communications Of Siam Bioscience Co Ltd , Siam Cement Group , Ministry Of Public Health , Department Of Medical Sciences , Siam Bioscience Co Ltd , National Vaccine Institute , His Majesty , Late King Rama , Siam Bioscience , Medical Sciences , Public Health , South East , Honorary Director , Corporate Communications , பெருநிறுவன தகவல்தொடர்புகள் ஆஃப் சியாம் உயிர் அறிவியல் இணை லிமிடெட் , சியாம் சிமென்ட் குழு , அமைச்சகம் ஆஃப் பொது ஆரோக்கியம் , துறை ஆஃப் மருத்துவ அறிவியல் , சியாம் உயிர் அறிவியல் இணை லிமிடெட் , தேசிய தடுப்பூசி நிறுவனம் , அவரது கம்பீரம் , தாமதமாக கிங் ராமா , சியாம் உயிர் அறிவியல் , மருத்துவ அறிவியல் , பொது ஆரோக்கியம் ,